There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Inovio Pharmaceuticals Inc (INO) shows that investor sentiment remained same, with the stock’s consolidated last price to $0.4291. The Inovio Pharmaceuticals Inc has recorded 52,084 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.43 and fluctuated between $0.4300 as its day high and $0.4000 as its day low. The current market capitalization of Inovio Pharmaceuticals Inc is $117.14M. A total of 2.23 million shares were traded on the day, compared to an average of 3.46M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, INO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 23 BUYs and 13 SELLs from insiders. Insiders purchased 696,584 shares during that period but sold 241,286.
In the most recent transaction, Zoth Lota S. sold 5,700 shares of INO for 0.56 per share on Jun 05. After the transaction, the Director now owns 52,716 company shares. In a previous transaction on Mar 13, Weiner David B. sold 5,833 shares at 1.15 per share. INO shares that Director owns now total 910,124.
Among the insiders who sold shares, Weiner David B. disposed of 11,668 shares on Feb 27 at a per-share price of $1.28. This resulted in the Director holding 904,291 shares of INO after the transaction.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for INO in the last 3 months, the mean price target is $0.40 with high estimates of $0.40 and low estimates of $0.40. In terms of 52-week highs and lows, INO has a high of $2.37 and a low of $0.32.
As of this writing, INO has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.15. The company reported an EPS of -$0.13 in the last quarter, which was 7.10% higher than expectations of -$0.14.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. INO’s latest balance sheet shows that the firm has $401.31M in Cash & Short Term Investments as of fiscal 2021. There were $33.02M in debt and $65.74M in liabilities at the time. Its Book Value Per Share was $0.51, while its Total Shareholder’s Equity was $399.67M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INO is Buy with a score of 2.80.